module.exports = [
  {
    "COHORT_DEFINITION_ID": "797617", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 797617- Citalopram", 
    "CONDITION_CONCEPT_ID": "312327", 
    "CONDITION_CONCEPT_NAME": "Acute myocardial infarction", 
    "NUM_PERSONS_POST_ITT": "3387", 
    "PT_ITT": "650518.323287", 
    "IR_ITT_1000PP": "5.206617367649"
  }, 
  {
    "COHORT_DEFINITION_ID": "743670", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 743670- venlafaxine", 
    "CONDITION_CONCEPT_ID": "312327", 
    "CONDITION_CONCEPT_NAME": "Acute myocardial infarction", 
    "NUM_PERSONS_POST_ITT": "1033", 
    "PT_ITT": "200583.897018", 
    "IR_ITT_1000PP": "5.14996475468467"
  }, 
  {
    "COHORT_DEFINITION_ID": "739138", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 739138- Sertraline", 
    "CONDITION_CONCEPT_ID": "31967", 
    "CONDITION_CONCEPT_NAME": "Nausea", 
    "NUM_PERSONS_POST_ITT": "6566", 
    "PT_ITT": "479025.415328", 
    "IR_ITT_1000PP": "13.7069971444085"
  }, 
  {
    "COHORT_DEFINITION_ID": "750982", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 750982- Bupropion", 
    "CONDITION_CONCEPT_ID": "133280", 
    "CONDITION_CONCEPT_NAME": "Alopecia", 
    "NUM_PERSONS_POST_ITT": "11", 
    "PT_ITT": "375594.044581", 
    "IR_ITT_1000PP": "0.0292869393397098"
  }, 
  {
    "COHORT_DEFINITION_ID": "755695", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 755695- Fluoxetine", 
    "CONDITION_CONCEPT_ID": "312327", 
    "CONDITION_CONCEPT_NAME": "Acute myocardial infarction", 
    "NUM_PERSONS_POST_ITT": "1541", 
    "PT_ITT": "455071.566106", 
    "IR_ITT_1000PP": "3.38628056502448"
  }, 
  {
    "COHORT_DEFINITION_ID": "715939", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 715939- Escitalopram", 
    "CONDITION_CONCEPT_ID": "436962", 
    "CONDITION_CONCEPT_NAME": "Insomnia", 
    "NUM_PERSONS_POST_ITT": "1263", 
    "PT_ITT": "280723.634836", 
    "IR_ITT_1000PP": "4.49908680021848"
  }, 
  {
    "COHORT_DEFINITION_ID": "797617", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 797617- Citalopram", 
    "CONDITION_CONCEPT_ID": "441284", 
    "CONDITION_CONCEPT_NAME": "Open-angle glaucoma", 
    "NUM_PERSONS_POST_ITT": "91", 
    "PT_ITT": "665007.483538", 
    "IR_ITT_1000PP": "0.136840565335984"
  }, 
  {
    "COHORT_DEFINITION_ID": "739138", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 739138- Sertraline", 
    "CONDITION_CONCEPT_ID": "436962", 
    "CONDITION_CONCEPT_NAME": "Insomnia", 
    "NUM_PERSONS_POST_ITT": "1891", 
    "PT_ITT": "508718.894883", 
    "IR_ITT_1000PP": "3.71718058641189"
  }, 
  {
    "COHORT_DEFINITION_ID": "750982", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 750982- Bupropion", 
    "CONDITION_CONCEPT_ID": "140673", 
    "CONDITION_CONCEPT_NAME": "Hypothyroidism", 
    "NUM_PERSONS_POST_ITT": "2981", 
    "PT_ITT": "357192.027953", 
    "IR_ITT_1000PP": "8.34565098522368"
  }, 
  {
    "COHORT_DEFINITION_ID": "743670", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 743670- venlafaxine", 
    "CONDITION_CONCEPT_ID": "377575", 
    "CONDITION_CONCEPT_NAME": "Tinnitus", 
    "NUM_PERSONS_POST_ITT": "24", 
    "PT_ITT": "204994.453073", 
    "IR_ITT_1000PP": "0.117076338604408"
  }, 
  {
    "COHORT_DEFINITION_ID": "710062", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 710062- Amitriptyline", 
    "CONDITION_CONCEPT_ID": "441284", 
    "CONDITION_CONCEPT_NAME": "Open-angle glaucoma", 
    "NUM_PERSONS_POST_ITT": "37", 
    "PT_ITT": "356155.244534", 
    "IR_ITT_1000PP": "0.103887281088368"
  }, 
  {
    "COHORT_DEFINITION_ID": "717607", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 717607- Desvenlafaxine", 
    "CONDITION_CONCEPT_ID": "31967", 
    "CONDITION_CONCEPT_NAME": "Nausea", 
    "NUM_PERSONS_POST_ITT": "861", 
    "PT_ITT": "46356.382566", 
    "IR_ITT_1000PP": "18.5734941412685"
  }, 
  {
    "COHORT_DEFINITION_ID": "750982", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 750982- Bupropion", 
    "CONDITION_CONCEPT_ID": "441284", 
    "CONDITION_CONCEPT_NAME": "Open-angle glaucoma", 
    "NUM_PERSONS_POST_ITT": "40", 
    "PT_ITT": "375546.033644", 
    "IR_ITT_1000PP": "0.106511576255704"
  }, 
  {
    "COHORT_DEFINITION_ID": "715259", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 715259- duloxetine", 
    "CONDITION_CONCEPT_ID": "377575", 
    "CONDITION_CONCEPT_NAME": "Tinnitus", 
    "NUM_PERSONS_POST_ITT": "53", 
    "PT_ITT": "285691.912978", 
    "IR_ITT_1000PP": "0.185514526636536"
  }, 
  {
    "COHORT_DEFINITION_ID": "710062", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 710062- Amitriptyline", 
    "CONDITION_CONCEPT_ID": "377575", 
    "CONDITION_CONCEPT_NAME": "Tinnitus", 
    "NUM_PERSONS_POST_ITT": "45", 
    "PT_ITT": "356039.964601", 
    "IR_ITT_1000PP": "0.126390305791738"
  }, 
  {
    "COHORT_DEFINITION_ID": "717607", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 717607- Desvenlafaxine", 
    "CONDITION_CONCEPT_ID": "75860", 
    "CONDITION_CONCEPT_NAME": "Constipation", 
    "NUM_PERSONS_POST_ITT": "517", 
    "PT_ITT": "49097.225301", 
    "IR_ITT_1000PP": "10.5301266381233"
  }, 
  {
    "COHORT_DEFINITION_ID": "755695", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 755695- Fluoxetine", 
    "CONDITION_CONCEPT_ID": "196523", 
    "CONDITION_CONCEPT_NAME": "Diarrhea", 
    "NUM_PERSONS_POST_ITT": "2802", 
    "PT_ITT": "447970.50809", 
    "IR_ITT_1000PP": "6.25487604518166"
  }, 
  {
    "COHORT_DEFINITION_ID": "40234834", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 40234834- vilazodone", 
    "CONDITION_CONCEPT_ID": "377575", 
    "CONDITION_CONCEPT_NAME": "Tinnitus", 
    "NUM_PERSONS_POST_ITT": "1", 
    "PT_ITT": "19752.319991", 
    "IR_ITT_1000PP": "0.0506269643492837"
  }, 
  {
    "COHORT_DEFINITION_ID": "725131", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 725131- Mirtazapine", 
    "CONDITION_CONCEPT_ID": "377575", 
    "CONDITION_CONCEPT_NAME": "Tinnitus", 
    "NUM_PERSONS_POST_ITT": "43", 
    "PT_ITT": "280761.884317", 
    "IR_ITT_1000PP": "0.153154692292384"
  }, 
  {
    "COHORT_DEFINITION_ID": "715939", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 715939- Escitalopram", 
    "CONDITION_CONCEPT_ID": "75860", 
    "CONDITION_CONCEPT_NAME": "Constipation", 
    "NUM_PERSONS_POST_ITT": "2857", 
    "PT_ITT": "272362.155535", 
    "IR_ITT_1000PP": "10.4897099025671"
  }, 
  {
    "COHORT_DEFINITION_ID": "739138", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 739138- Sertraline", 
    "CONDITION_CONCEPT_ID": "441284", 
    "CONDITION_CONCEPT_NAME": "Open-angle glaucoma", 
    "NUM_PERSONS_POST_ITT": "66", 
    "PT_ITT": "516687.527903", 
    "IR_ITT_1000PP": "0.127736777908815"
  }, 
  {
    "COHORT_DEFINITION_ID": "797617", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 797617- Citalopram", 
    "CONDITION_CONCEPT_ID": "196523", 
    "CONDITION_CONCEPT_NAME": "Diarrhea", 
    "NUM_PERSONS_POST_ITT": "5459", 
    "PT_ITT": "639107.193386", 
    "IR_ITT_1000PP": "8.54160312463099"
  }, 
  {
    "COHORT_DEFINITION_ID": "738156", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 738156- Doxepin", 
    "CONDITION_CONCEPT_ID": "75860", 
    "CONDITION_CONCEPT_NAME": "Constipation", 
    "NUM_PERSONS_POST_ITT": "828", 
    "PT_ITT": "70510.58987", 
    "IR_ITT_1000PP": "11.742916936684"
  }, 
  {
    "COHORT_DEFINITION_ID": "722031", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 722031- Paroxetine", 
    "CONDITION_CONCEPT_ID": "441284", 
    "CONDITION_CONCEPT_NAME": "Open-angle glaucoma", 
    "NUM_PERSONS_POST_ITT": "1", 
    "PT_ITT": "14254.609291", 
    "IR_ITT_1000PP": "0.0701527470578499"
  }, 
  {
    "COHORT_DEFINITION_ID": "721724", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 721724- Nortriptyline", 
    "CONDITION_CONCEPT_ID": "196523", 
    "CONDITION_CONCEPT_NAME": "Diarrhea", 
    "NUM_PERSONS_POST_ITT": "829", 
    "PT_ITT": "82155.072122", 
    "IR_ITT_1000PP": "10.0906733886003"
  }, 
  {
    "COHORT_DEFINITION_ID": "797617", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 797617- Citalopram", 
    "CONDITION_CONCEPT_ID": "133280", 
    "CONDITION_CONCEPT_NAME": "Alopecia", 
    "NUM_PERSONS_POST_ITT": "39", 
    "PT_ITT": "665286.51975", 
    "IR_ITT_1000PP": "0.0586213591320854"
  }, 
  {
    "COHORT_DEFINITION_ID": "725131", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 725131- Mirtazapine", 
    "CONDITION_CONCEPT_ID": "133280", 
    "CONDITION_CONCEPT_NAME": "Alopecia", 
    "NUM_PERSONS_POST_ITT": "16", 
    "PT_ITT": "280912.279907", 
    "IR_ITT_1000PP": "0.0569572821996141"
  }, 
  {
    "COHORT_DEFINITION_ID": "40234834", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 40234834- vilazodone", 
    "CONDITION_CONCEPT_ID": "75860", 
    "CONDITION_CONCEPT_NAME": "Constipation", 
    "NUM_PERSONS_POST_ITT": "171", 
    "PT_ITT": "18637.007494", 
    "IR_ITT_1000PP": "9.17529276387595"
  }, 
  {
    "COHORT_DEFINITION_ID": "717607", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 717607- Desvenlafaxine", 
    "CONDITION_CONCEPT_ID": "436962", 
    "CONDITION_CONCEPT_NAME": "Insomnia", 
    "NUM_PERSONS_POST_ITT": "275", 
    "PT_ITT": "50538.432381", 
    "IR_ITT_1000PP": "5.44140344375594"
  }, 
  {
    "COHORT_DEFINITION_ID": "703547", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 703547- Trazodone", 
    "CONDITION_CONCEPT_ID": "436962", 
    "CONDITION_CONCEPT_NAME": "Insomnia", 
    "NUM_PERSONS_POST_ITT": "3735", 
    "PT_ITT": "606748.943989", 
    "IR_ITT_1000PP": "6.15575855055417"
  }, 
  {
    "COHORT_DEFINITION_ID": "715259", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 715259- duloxetine", 
    "CONDITION_CONCEPT_ID": "75860", 
    "CONDITION_CONCEPT_NAME": "Constipation", 
    "NUM_PERSONS_POST_ITT": "3560", 
    "PT_ITT": "268236.595763", 
    "IR_ITT_1000PP": "13.2718654211726"
  }, 
  {
    "COHORT_DEFINITION_ID": "738156", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 738156- Doxepin", 
    "CONDITION_CONCEPT_ID": "436962", 
    "CONDITION_CONCEPT_NAME": "Insomnia", 
    "NUM_PERSONS_POST_ITT": "452", 
    "PT_ITT": "72666.080178", 
    "IR_ITT_1000PP": "6.22023368940224"
  }, 
  {
    "COHORT_DEFINITION_ID": "755695", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 755695- Fluoxetine", 
    "CONDITION_CONCEPT_ID": "75860", 
    "CONDITION_CONCEPT_NAME": "Constipation", 
    "NUM_PERSONS_POST_ITT": "3390", 
    "PT_ITT": "444487.924296", 
    "IR_ITT_1000PP": "7.62675387721553"
  }, 
  {
    "COHORT_DEFINITION_ID": "722031", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 722031- Paroxetine", 
    "CONDITION_CONCEPT_ID": "196523", 
    "CONDITION_CONCEPT_NAME": "Diarrhea", 
    "NUM_PERSONS_POST_ITT": "98", 
    "PT_ITT": "13736.983109", 
    "IR_ITT_1000PP": "7.1340263886467"
  }, 
  {
    "COHORT_DEFINITION_ID": "721724", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 721724- Nortriptyline", 
    "CONDITION_CONCEPT_ID": "140673", 
    "CONDITION_CONCEPT_NAME": "Hypothyroidism", 
    "NUM_PERSONS_POST_ITT": "722", 
    "PT_ITT": "82530.365608", 
    "IR_ITT_1000PP": "8.74829518421537"
  }, 
  {
    "COHORT_DEFINITION_ID": "739138", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 739138- Sertraline", 
    "CONDITION_CONCEPT_ID": "196523", 
    "CONDITION_CONCEPT_NAME": "Diarrhea", 
    "NUM_PERSONS_POST_ITT": "3350", 
    "PT_ITT": "499997.437617", 
    "IR_ITT_1000PP": "6.70003433610816"
  }, 
  {
    "COHORT_DEFINITION_ID": "738156", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 738156- Doxepin", 
    "CONDITION_CONCEPT_ID": "441284", 
    "CONDITION_CONCEPT_NAME": "Open-angle glaucoma", 
    "NUM_PERSONS_POST_ITT": "7", 
    "PT_ITT": "75277.835875", 
    "IR_ITT_1000PP": "0.0929888581231746"
  }, 
  {
    "COHORT_DEFINITION_ID": "715259", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 715259- duloxetine", 
    "CONDITION_CONCEPT_ID": "196523", 
    "CONDITION_CONCEPT_NAME": "Diarrhea", 
    "NUM_PERSONS_POST_ITT": "3177", 
    "PT_ITT": "270259.615209", 
    "IR_ITT_1000PP": "11.7553634402355"
  }, 
  {
    "COHORT_DEFINITION_ID": "743670", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 743670- venlafaxine", 
    "CONDITION_CONCEPT_ID": "373995", 
    "CONDITION_CONCEPT_NAME": "Delirium", 
    "NUM_PERSONS_POST_ITT": "1173", 
    "PT_ITT": "199647.858869", 
    "IR_ITT_1000PP": "5.87534475273121"
  }, 
  {
    "COHORT_DEFINITION_ID": "722031", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 722031- Paroxetine", 
    "CONDITION_CONCEPT_ID": "377575", 
    "CONDITION_CONCEPT_NAME": "Tinnitus", 
    "NUM_PERSONS_POST_ITT": "1", 
    "PT_ITT": "14261.171919", 
    "IR_ITT_1000PP": "0.0701204645508628"
  }, 
  {
    "COHORT_DEFINITION_ID": "725131", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 725131- Mirtazapine", 
    "CONDITION_CONCEPT_ID": "441284", 
    "CONDITION_CONCEPT_NAME": "Open-angle glaucoma", 
    "NUM_PERSONS_POST_ITT": "88", 
    "PT_ITT": "280565.637953", 
    "IR_ITT_1000PP": "0.313652094540322"
  }, 
  {
    "COHORT_DEFINITION_ID": "717607", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 717607- Desvenlafaxine", 
    "CONDITION_CONCEPT_ID": "377575", 
    "CONDITION_CONCEPT_NAME": "Tinnitus", 
    "NUM_PERSONS_POST_ITT": "7", 
    "PT_ITT": "52055.943355", 
    "IR_ITT_1000PP": "0.134470716480209"
  }, 
  {
    "COHORT_DEFINITION_ID": "797617", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 797617- Citalopram", 
    "CONDITION_CONCEPT_ID": "140673", 
    "CONDITION_CONCEPT_NAME": "Hypothyroidism", 
    "NUM_PERSONS_POST_ITT": "5289", 
    "PT_ITT": "633447.809972", 
    "IR_ITT_1000PP": "8.34954343000063"
  }, 
  {
    "COHORT_DEFINITION_ID": "40234834", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 40234834- vilazodone", 
    "CONDITION_CONCEPT_ID": "373995", 
    "CONDITION_CONCEPT_NAME": "Delirium", 
    "NUM_PERSONS_POST_ITT": "112", 
    "PT_ITT": "19086.22298", 
    "IR_ITT_1000PP": "5.86810706955285"
  }, 
  {
    "COHORT_DEFINITION_ID": "710062", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 710062- Amitriptyline", 
    "CONDITION_CONCEPT_ID": "31967", 
    "CONDITION_CONCEPT_NAME": "Nausea", 
    "NUM_PERSONS_POST_ITT": "5956", 
    "PT_ITT": "319458.154654", 
    "IR_ITT_1000PP": "18.6440693819535"
  }, 
  {
    "COHORT_DEFINITION_ID": "738156", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 738156- Doxepin", 
    "CONDITION_CONCEPT_ID": "31967", 
    "CONDITION_CONCEPT_NAME": "Nausea", 
    "NUM_PERSONS_POST_ITT": "1329", 
    "PT_ITT": "66300.81126", 
    "IR_ITT_1000PP": "20.0450035941234"
  }, 
  {
    "COHORT_DEFINITION_ID": "797617", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 797617- Citalopram", 
    "CONDITION_CONCEPT_ID": "75860", 
    "CONDITION_CONCEPT_NAME": "Constipation", 
    "NUM_PERSONS_POST_ITT": "6060", 
    "PT_ITT": "634796.218177", 
    "IR_ITT_1000PP": "9.54637067215528"
  }, 
  {
    "COHORT_DEFINITION_ID": "721724", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 721724- Nortriptyline", 
    "CONDITION_CONCEPT_ID": "441284", 
    "CONDITION_CONCEPT_NAME": "Open-angle glaucoma", 
    "NUM_PERSONS_POST_ITT": "11", 
    "PT_ITT": "87039.867649", 
    "IR_ITT_1000PP": "0.126378868639357"
  }, 
  {
    "COHORT_DEFINITION_ID": "743670", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 743670- venlafaxine", 
    "CONDITION_CONCEPT_ID": "441284", 
    "CONDITION_CONCEPT_NAME": "Open-angle glaucoma", 
    "NUM_PERSONS_POST_ITT": "27", 
    "PT_ITT": "205050.280575", 
    "IR_ITT_1000PP": "0.13167502099625"
  }, 
  {
    "COHORT_DEFINITION_ID": "717607", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 717607- Desvenlafaxine", 
    "CONDITION_CONCEPT_ID": "140673", 
    "CONDITION_CONCEPT_NAME": "Hypothyroidism", 
    "NUM_PERSONS_POST_ITT": "571", 
    "PT_ITT": "48030.753177", 
    "IR_ITT_1000PP": "11.8882166576857"
  }, 
  {
    "COHORT_DEFINITION_ID": "715939", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 715939- Escitalopram", 
    "CONDITION_CONCEPT_ID": "377091", 
    "CONDITION_CONCEPT_NAME": "Seizure", 
    "NUM_PERSONS_POST_ITT": "2398", 
    "PT_ITT": "270447.371134", 
    "IR_ITT_1000PP": "8.86678983029142"
  }, 
  {
    "COHORT_DEFINITION_ID": "710062", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 710062- Amitriptyline", 
    "CONDITION_CONCEPT_ID": "377091", 
    "CONDITION_CONCEPT_NAME": "Seizure", 
    "NUM_PERSONS_POST_ITT": "2816", 
    "PT_ITT": "338961.794369", 
    "IR_ITT_1000PP": "8.30772094902959"
  }, 
  {
    "COHORT_DEFINITION_ID": "743670", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 743670- venlafaxine", 
    "CONDITION_CONCEPT_ID": "377091", 
    "CONDITION_CONCEPT_NAME": "Seizure", 
    "NUM_PERSONS_POST_ITT": "1745", 
    "PT_ITT": "192988.226971", 
    "IR_ITT_1000PP": "9.0420023407035"
  }, 
  {
    "COHORT_DEFINITION_ID": "717607", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 717607- Desvenlafaxine", 
    "CONDITION_CONCEPT_ID": "441284", 
    "CONDITION_CONCEPT_NAME": "Open-angle glaucoma", 
    "NUM_PERSONS_POST_ITT": "4", 
    "PT_ITT": "52082.100776", 
    "IR_ITT_1000PP": "0.0768018175227533"
  }, 
  {
    "COHORT_DEFINITION_ID": "755695", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 755695- Fluoxetine", 
    "CONDITION_CONCEPT_ID": "377091", 
    "CONDITION_CONCEPT_NAME": "Seizure", 
    "NUM_PERSONS_POST_ITT": "3083", 
    "PT_ITT": "442145.312537", 
    "IR_ITT_1000PP": "6.97282072789589"
  }, 
  {
    "COHORT_DEFINITION_ID": "739138", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 739138- Sertraline", 
    "CONDITION_CONCEPT_ID": "312327", 
    "CONDITION_CONCEPT_NAME": "Acute myocardial infarction", 
    "NUM_PERSONS_POST_ITT": "1944", 
    "PT_ITT": "508046.71159", 
    "IR_ITT_1000PP": "3.82641980678507"
  }, 
  {
    "COHORT_DEFINITION_ID": "739138", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 739138- Sertraline", 
    "CONDITION_CONCEPT_ID": "140673", 
    "CONDITION_CONCEPT_NAME": "Hypothyroidism", 
    "NUM_PERSONS_POST_ITT": "3324", 
    "PT_ITT": "496974.774001", 
    "IR_ITT_1000PP": "6.68846825612382"
  }, 
  {
    "COHORT_DEFINITION_ID": "721724", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 721724- Nortriptyline", 
    "CONDITION_CONCEPT_ID": "377575", 
    "CONDITION_CONCEPT_NAME": "Tinnitus", 
    "NUM_PERSONS_POST_ITT": "16", 
    "PT_ITT": "86976.267388", 
    "IR_ITT_1000PP": "0.183958227692437"
  }, 
  {
    "COHORT_DEFINITION_ID": "703547", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 703547- Trazodone", 
    "CONDITION_CONCEPT_ID": "377575", 
    "CONDITION_CONCEPT_NAME": "Tinnitus", 
    "NUM_PERSONS_POST_ITT": "96", 
    "PT_ITT": "622879.935265", 
    "IR_ITT_1000PP": "0.154122800502728"
  }, 
  {
    "COHORT_DEFINITION_ID": "725131", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 725131- Mirtazapine", 
    "CONDITION_CONCEPT_ID": "377091", 
    "CONDITION_CONCEPT_NAME": "Seizure", 
    "NUM_PERSONS_POST_ITT": "2875", 
    "PT_ITT": "260613.513648", 
    "IR_ITT_1000PP": "11.0316612510092"
  }, 
  {
    "COHORT_DEFINITION_ID": "750982", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 750982- Bupropion", 
    "CONDITION_CONCEPT_ID": "436962", 
    "CONDITION_CONCEPT_NAME": "Insomnia", 
    "NUM_PERSONS_POST_ITT": "1580", 
    "PT_ITT": "368361.857445", 
    "IR_ITT_1000PP": "4.28926059543477"
  }, 
  {
    "COHORT_DEFINITION_ID": "722031", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 722031- Paroxetine", 
    "CONDITION_CONCEPT_ID": "133280", 
    "CONDITION_CONCEPT_NAME": "Alopecia", 
    "NUM_PERSONS_POST_ITT": "0", 
    "PT_ITT": "14257.763295", 
    "IR_ITT_1000PP": "0"
  }, 
  {
    "COHORT_DEFINITION_ID": "715939", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 715939- Escitalopram", 
    "CONDITION_CONCEPT_ID": "312327", 
    "CONDITION_CONCEPT_NAME": "Acute myocardial infarction", 
    "NUM_PERSONS_POST_ITT": "1514", 
    "PT_ITT": "279965.874628", 
    "IR_ITT_1000PP": "5.40780194018897"
  }, 
  {
    "COHORT_DEFINITION_ID": "750982", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 750982- Bupropion", 
    "CONDITION_CONCEPT_ID": "377091", 
    "CONDITION_CONCEPT_NAME": "Seizure", 
    "NUM_PERSONS_POST_ITT": "2248", 
    "PT_ITT": "363051.17261", 
    "IR_ITT_1000PP": "6.19196457578961"
  }, 
  {
    "COHORT_DEFINITION_ID": "739138", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 739138- Sertraline", 
    "CONDITION_CONCEPT_ID": "75860", 
    "CONDITION_CONCEPT_NAME": "Constipation", 
    "NUM_PERSONS_POST_ITT": "3994", 
    "PT_ITT": "495914.065512", 
    "IR_ITT_1000PP": "8.05381471863769"
  }, 
  {
    "COHORT_DEFINITION_ID": "721724", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 721724- Nortriptyline", 
    "CONDITION_CONCEPT_ID": "31967", 
    "CONDITION_CONCEPT_NAME": "Nausea", 
    "NUM_PERSONS_POST_ITT": "1566", 
    "PT_ITT": "76261.876972", 
    "IR_ITT_1000PP": "20.5345063900665"
  }, 
  {
    "COHORT_DEFINITION_ID": "717607", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 717607- Desvenlafaxine", 
    "CONDITION_CONCEPT_ID": "133280", 
    "CONDITION_CONCEPT_NAME": "Alopecia", 
    "NUM_PERSONS_POST_ITT": "1", 
    "PT_ITT": "52082.796189", 
    "IR_ITT_1000PP": "0.0192001980149292"
  }, 
  {
    "COHORT_DEFINITION_ID": "703547", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 703547- Trazodone", 
    "CONDITION_CONCEPT_ID": "133280", 
    "CONDITION_CONCEPT_NAME": "Alopecia", 
    "NUM_PERSONS_POST_ITT": "40", 
    "PT_ITT": "623134.339056", 
    "IR_ITT_1000PP": "0.0641916156644439"
  }, 
  {
    "COHORT_DEFINITION_ID": "722031", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 722031- Paroxetine", 
    "CONDITION_CONCEPT_ID": "373995", 
    "CONDITION_CONCEPT_NAME": "Delirium", 
    "NUM_PERSONS_POST_ITT": "68", 
    "PT_ITT": "14005.470402", 
    "IR_ITT_1000PP": "4.85524570387079"
  }, 
  {
    "COHORT_DEFINITION_ID": "717607", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 717607- Desvenlafaxine", 
    "CONDITION_CONCEPT_ID": "196523", 
    "CONDITION_CONCEPT_NAME": "Diarrhea", 
    "NUM_PERSONS_POST_ITT": "483", 
    "PT_ITT": "49357.843973", 
    "IR_ITT_1000PP": "9.78567865047374"
  }, 
  {
    "COHORT_DEFINITION_ID": "750982", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 750982- Bupropion", 
    "CONDITION_CONCEPT_ID": "31967", 
    "CONDITION_CONCEPT_NAME": "Nausea", 
    "NUM_PERSONS_POST_ITT": "5236", 
    "PT_ITT": "346052.767348", 
    "IR_ITT_1000PP": "15.1306404515313"
  }, 
  {
    "COHORT_DEFINITION_ID": "40234834", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 40234834- vilazodone", 
    "CONDITION_CONCEPT_ID": "377091", 
    "CONDITION_CONCEPT_NAME": "Seizure", 
    "NUM_PERSONS_POST_ITT": "141", 
    "PT_ITT": "18482.225872", 
    "IR_ITT_1000PP": "7.62895124085734"
  }, 
  {
    "COHORT_DEFINITION_ID": "755695", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 755695- Fluoxetine", 
    "CONDITION_CONCEPT_ID": "377575", 
    "CONDITION_CONCEPT_NAME": "Tinnitus", 
    "NUM_PERSONS_POST_ITT": "48", 
    "PT_ITT": "461471.786351", 
    "IR_ITT_1000PP": "0.104015026312986"
  }, 
  {
    "COHORT_DEFINITION_ID": "738156", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 738156- Doxepin", 
    "CONDITION_CONCEPT_ID": "377575", 
    "CONDITION_CONCEPT_NAME": "Tinnitus", 
    "NUM_PERSONS_POST_ITT": "11", 
    "PT_ITT": "75235.073398", 
    "IR_ITT_1000PP": "0.146208403915672"
  }, 
  {
    "COHORT_DEFINITION_ID": "739138", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 739138- Sertraline", 
    "CONDITION_CONCEPT_ID": "377575", 
    "CONDITION_CONCEPT_NAME": "Tinnitus", 
    "NUM_PERSONS_POST_ITT": "51", 
    "PT_ITT": "516667.809913", 
    "IR_ITT_1000PP": "0.098709459001496"
  }, 
  {
    "COHORT_DEFINITION_ID": "750982", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 750982- Bupropion", 
    "CONDITION_CONCEPT_ID": "377575", 
    "CONDITION_CONCEPT_NAME": "Tinnitus", 
    "NUM_PERSONS_POST_ITT": "44", 
    "PT_ITT": "375461.669519", 
    "IR_ITT_1000PP": "0.117189059688484"
  }, 
  {
    "COHORT_DEFINITION_ID": "40234834", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 40234834- vilazodone", 
    "CONDITION_CONCEPT_ID": "312327", 
    "CONDITION_CONCEPT_NAME": "Acute myocardial infarction", 
    "NUM_PERSONS_POST_ITT": "62", 
    "PT_ITT": "19332.180482", 
    "IR_ITT_1000PP": "3.20708779114325"
  }, 
  {
    "COHORT_DEFINITION_ID": "717607", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 717607- Desvenlafaxine", 
    "CONDITION_CONCEPT_ID": "312327", 
    "CONDITION_CONCEPT_NAME": "Acute myocardial infarction", 
    "NUM_PERSONS_POST_ITT": "248", 
    "PT_ITT": "50909.372762", 
    "IR_ITT_1000PP": "4.87140160141814"
  }, 
  {
    "COHORT_DEFINITION_ID": "710062", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 710062- Amitriptyline", 
    "CONDITION_CONCEPT_ID": "133280", 
    "CONDITION_CONCEPT_NAME": "Alopecia", 
    "NUM_PERSONS_POST_ITT": "22", 
    "PT_ITT": "356158.691481", 
    "IR_ITT_1000PP": "0.0617702179568279"
  }, 
  {
    "COHORT_DEFINITION_ID": "703547", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 703547- Trazodone", 
    "CONDITION_CONCEPT_ID": "196523", 
    "CONDITION_CONCEPT_NAME": "Diarrhea", 
    "NUM_PERSONS_POST_ITT": "4948", 
    "PT_ITT": "597664.349049", 
    "IR_ITT_1000PP": "8.27889434575314"
  }, 
  {
    "COHORT_DEFINITION_ID": "710062", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 710062- Amitriptyline", 
    "CONDITION_CONCEPT_ID": "312327", 
    "CONDITION_CONCEPT_NAME": "Acute myocardial infarction", 
    "NUM_PERSONS_POST_ITT": "1803", 
    "PT_ITT": "348155.673459", 
    "IR_ITT_1000PP": "5.17871784792939"
  }, 
  {
    "COHORT_DEFINITION_ID": "750982", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 750982- Bupropion", 
    "CONDITION_CONCEPT_ID": "312327", 
    "CONDITION_CONCEPT_NAME": "Acute myocardial infarction", 
    "NUM_PERSONS_POST_ITT": "1661", 
    "PT_ITT": "367459.196379", 
    "IR_ITT_1000PP": "4.520229773449"
  }, 
  {
    "COHORT_DEFINITION_ID": "725131", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 725131- Mirtazapine", 
    "CONDITION_CONCEPT_ID": "312327", 
    "CONDITION_CONCEPT_NAME": "Acute myocardial infarction", 
    "NUM_PERSONS_POST_ITT": "1779", 
    "PT_ITT": "273031.000735", 
    "IR_ITT_1000PP": "6.51574361596642"
  }, 
  {
    "COHORT_DEFINITION_ID": "40234834", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 40234834- vilazodone", 
    "CONDITION_CONCEPT_ID": "441284", 
    "CONDITION_CONCEPT_NAME": "Open-angle glaucoma", 
    "NUM_PERSONS_POST_ITT": "6", 
    "PT_ITT": "19754.140662", 
    "IR_ITT_1000PP": "0.303733789419749"
  }, 
  {
    "COHORT_DEFINITION_ID": "755695", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 755695- Fluoxetine", 
    "CONDITION_CONCEPT_ID": "31967", 
    "CONDITION_CONCEPT_NAME": "Nausea", 
    "NUM_PERSONS_POST_ITT": "5731", 
    "PT_ITT": "429839.563408", 
    "IR_ITT_1000PP": "13.3328815862401"
  }, 
  {
    "COHORT_DEFINITION_ID": "755695", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 755695- Fluoxetine", 
    "CONDITION_CONCEPT_ID": "441284", 
    "CONDITION_CONCEPT_NAME": "Open-angle glaucoma", 
    "NUM_PERSONS_POST_ITT": "30", 
    "PT_ITT": "461560.747303", 
    "IR_ITT_1000PP": "0.0649968615730357"
  }, 
  {
    "COHORT_DEFINITION_ID": "738156", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 738156- Doxepin", 
    "CONDITION_CONCEPT_ID": "196523", 
    "CONDITION_CONCEPT_NAME": "Diarrhea", 
    "NUM_PERSONS_POST_ITT": "739", 
    "PT_ITT": "70897.710947", 
    "IR_ITT_1000PP": "10.4234676991538"
  }, 
  {
    "COHORT_DEFINITION_ID": "750982", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 750982- Bupropion", 
    "CONDITION_CONCEPT_ID": "75860", 
    "CONDITION_CONCEPT_NAME": "Constipation", 
    "NUM_PERSONS_POST_ITT": "3061", 
    "PT_ITT": "360021.722361", 
    "IR_ITT_1000PP": "8.50226475204372"
  }, 
  {
    "COHORT_DEFINITION_ID": "738156", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 738156- Doxepin", 
    "CONDITION_CONCEPT_ID": "373995", 
    "CONDITION_CONCEPT_NAME": "Delirium", 
    "NUM_PERSONS_POST_ITT": "524", 
    "PT_ITT": "72617.631216", 
    "IR_ITT_1000PP": "7.21587844749948"
  }, 
  {
    "COHORT_DEFINITION_ID": "755695", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 755695- Fluoxetine", 
    "CONDITION_CONCEPT_ID": "133280", 
    "CONDITION_CONCEPT_NAME": "Alopecia", 
    "NUM_PERSONS_POST_ITT": "28", 
    "PT_ITT": "461519.320899", 
    "IR_ITT_1000PP": "0.0606691827017305"
  }, 
  {
    "COHORT_DEFINITION_ID": "721724", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 721724- Nortriptyline", 
    "CONDITION_CONCEPT_ID": "312327", 
    "CONDITION_CONCEPT_NAME": "Acute myocardial infarction", 
    "NUM_PERSONS_POST_ITT": "448", 
    "PT_ITT": "85055.180962", 
    "IR_ITT_1000PP": "5.26716885359579"
  }, 
  {
    "COHORT_DEFINITION_ID": "717607", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 717607- Desvenlafaxine", 
    "CONDITION_CONCEPT_ID": "377091", 
    "CONDITION_CONCEPT_NAME": "Seizure", 
    "NUM_PERSONS_POST_ITT": "396", 
    "PT_ITT": "48857.055524", 
    "IR_ITT_1000PP": "8.10527764624443"
  }, 
  {
    "COHORT_DEFINITION_ID": "715939", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 715939- Escitalopram", 
    "CONDITION_CONCEPT_ID": "133280", 
    "CONDITION_CONCEPT_NAME": "Alopecia", 
    "NUM_PERSONS_POST_ITT": "21", 
    "PT_ITT": "286834.645053", 
    "IR_ITT_1000PP": "0.0732129133010404"
  }, 
  {
    "COHORT_DEFINITION_ID": "715259", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 715259- duloxetine", 
    "CONDITION_CONCEPT_ID": "312327", 
    "CONDITION_CONCEPT_NAME": "Acute myocardial infarction", 
    "NUM_PERSONS_POST_ITT": "1992", 
    "PT_ITT": "277216.339273", 
    "IR_ITT_1000PP": "7.18572363095199"
  }, 
  {
    "COHORT_DEFINITION_ID": "710062", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 710062- Amitriptyline", 
    "CONDITION_CONCEPT_ID": "373995", 
    "CONDITION_CONCEPT_NAME": "Delirium", 
    "NUM_PERSONS_POST_ITT": "1679", 
    "PT_ITT": "349231.517167", 
    "IR_ITT_1000PP": "4.80769895460814"
  }, 
  {
    "COHORT_DEFINITION_ID": "703547", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 703547- Trazodone", 
    "CONDITION_CONCEPT_ID": "373995", 
    "CONDITION_CONCEPT_NAME": "Delirium", 
    "NUM_PERSONS_POST_ITT": "3740", 
    "PT_ITT": "605299.791613", 
    "IR_ITT_1000PP": "6.1787564638568"
  }, 
  {
    "COHORT_DEFINITION_ID": "725131", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 725131- Mirtazapine", 
    "CONDITION_CONCEPT_ID": "140673", 
    "CONDITION_CONCEPT_NAME": "Hypothyroidism", 
    "NUM_PERSONS_POST_ITT": "2417", 
    "PT_ITT": "264695.714105", 
    "IR_ITT_1000PP": "9.13123965067761"
  }, 
  {
    "COHORT_DEFINITION_ID": "40234834", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 40234834- vilazodone", 
    "CONDITION_CONCEPT_ID": "436962", 
    "CONDITION_CONCEPT_NAME": "Insomnia", 
    "NUM_PERSONS_POST_ITT": "109", 
    "PT_ITT": "19094.502244", 
    "IR_ITT_1000PP": "5.70844940638611"
  }, 
  {
    "COHORT_DEFINITION_ID": "715939", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 715939- Escitalopram", 
    "CONDITION_CONCEPT_ID": "373995", 
    "CONDITION_CONCEPT_NAME": "Delirium", 
    "NUM_PERSONS_POST_ITT": "1753", 
    "PT_ITT": "278936.245781", 
    "IR_ITT_1000PP": "6.28459021197383"
  }, 
  {
    "COHORT_DEFINITION_ID": "715939", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 715939- Escitalopram", 
    "CONDITION_CONCEPT_ID": "31967", 
    "CONDITION_CONCEPT_NAME": "Nausea", 
    "NUM_PERSONS_POST_ITT": "4330", 
    "PT_ITT": "261958.053883", 
    "IR_ITT_1000PP": "16.5293639031764"
  }, 
  {
    "COHORT_DEFINITION_ID": "755695", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 755695- Fluoxetine", 
    "CONDITION_CONCEPT_ID": "436962", 
    "CONDITION_CONCEPT_NAME": "Insomnia", 
    "NUM_PERSONS_POST_ITT": "1975", 
    "PT_ITT": "453773.447457", 
    "IR_ITT_1000PP": "4.35239217073659"
  }, 
  {
    "COHORT_DEFINITION_ID": "40234834", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 40234834- vilazodone", 
    "CONDITION_CONCEPT_ID": "140673", 
    "CONDITION_CONCEPT_NAME": "Hypothyroidism", 
    "NUM_PERSONS_POST_ITT": "212", 
    "PT_ITT": "18125.240344", 
    "IR_ITT_1000PP": "11.6963966257241"
  }, 
  {
    "COHORT_DEFINITION_ID": "721724", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 721724- Nortriptyline", 
    "CONDITION_CONCEPT_ID": "373995", 
    "CONDITION_CONCEPT_NAME": "Delirium", 
    "NUM_PERSONS_POST_ITT": "426", 
    "PT_ITT": "85206.000883", 
    "IR_ITT_1000PP": "4.99964786030691"
  }, 
  {
    "COHORT_DEFINITION_ID": "725131", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 725131- Mirtazapine", 
    "CONDITION_CONCEPT_ID": "196523", 
    "CONDITION_CONCEPT_NAME": "Diarrhea", 
    "NUM_PERSONS_POST_ITT": "2910", 
    "PT_ITT": "265692.24259", 
    "IR_ITT_1000PP": "10.9525215024457"
  }, 
  {
    "COHORT_DEFINITION_ID": "715259", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 715259- duloxetine", 
    "CONDITION_CONCEPT_ID": "133280", 
    "CONDITION_CONCEPT_NAME": "Alopecia", 
    "NUM_PERSONS_POST_ITT": "17", 
    "PT_ITT": "285965.927992", 
    "IR_ITT_1000PP": "0.0594476416102116"
  }, 
  {
    "COHORT_DEFINITION_ID": "722031", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 722031- Paroxetine", 
    "CONDITION_CONCEPT_ID": "75860", 
    "CONDITION_CONCEPT_NAME": "Constipation", 
    "NUM_PERSONS_POST_ITT": "121", 
    "PT_ITT": "13605.623792", 
    "IR_ITT_1000PP": "8.89338128481452"
  }, 
  {
    "COHORT_DEFINITION_ID": "721724", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 721724- Nortriptyline", 
    "CONDITION_CONCEPT_ID": "133280", 
    "CONDITION_CONCEPT_NAME": "Alopecia", 
    "NUM_PERSONS_POST_ITT": "4", 
    "PT_ITT": "87052.976476", 
    "IR_ITT_1000PP": "0.0459490319794267"
  }, 
  {
    "COHORT_DEFINITION_ID": "715939", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 715939- Escitalopram", 
    "CONDITION_CONCEPT_ID": "196523", 
    "CONDITION_CONCEPT_NAME": "Diarrhea", 
    "NUM_PERSONS_POST_ITT": "2377", 
    "PT_ITT": "275043.712839", 
    "IR_ITT_1000PP": "8.64226262605539"
  }, 
  {
    "COHORT_DEFINITION_ID": "40234834", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 40234834- vilazodone", 
    "CONDITION_CONCEPT_ID": "133280", 
    "CONDITION_CONCEPT_NAME": "Alopecia", 
    "NUM_PERSONS_POST_ITT": "1", 
    "PT_ITT": "19766.080427", 
    "IR_ITT_1000PP": "0.0505917196731641"
  }, 
  {
    "COHORT_DEFINITION_ID": "725131", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 725131- Mirtazapine", 
    "CONDITION_CONCEPT_ID": "75860", 
    "CONDITION_CONCEPT_NAME": "Constipation", 
    "NUM_PERSONS_POST_ITT": "3381", 
    "PT_ITT": "262696.993488", 
    "IR_ITT_1000PP": "12.8703414344727"
  }, 
  {
    "COHORT_DEFINITION_ID": "743670", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 743670- venlafaxine", 
    "CONDITION_CONCEPT_ID": "133280", 
    "CONDITION_CONCEPT_NAME": "Alopecia", 
    "NUM_PERSONS_POST_ITT": "17", 
    "PT_ITT": "205076.312057", 
    "IR_ITT_1000PP": "0.0828959709167918"
  }, 
  {
    "COHORT_DEFINITION_ID": "721724", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 721724- Nortriptyline", 
    "CONDITION_CONCEPT_ID": "75860", 
    "CONDITION_CONCEPT_NAME": "Constipation", 
    "NUM_PERSONS_POST_ITT": "974", 
    "PT_ITT": "81801.407584", 
    "IR_ITT_1000PP": "11.9068855752858"
  }, 
  {
    "COHORT_DEFINITION_ID": "797617", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 797617- Citalopram", 
    "CONDITION_CONCEPT_ID": "377575", 
    "CONDITION_CONCEPT_NAME": "Tinnitus", 
    "NUM_PERSONS_POST_ITT": "86", 
    "PT_ITT": "665011.165943", 
    "IR_ITT_1000PP": "0.129321136853469"
  }, 
  {
    "COHORT_DEFINITION_ID": "40234834", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 40234834- vilazodone", 
    "CONDITION_CONCEPT_ID": "196523", 
    "CONDITION_CONCEPT_NAME": "Diarrhea", 
    "NUM_PERSONS_POST_ITT": "175", 
    "PT_ITT": "18679.518095", 
    "IR_ITT_1000PP": "9.36855004020916"
  }, 
  {
    "COHORT_DEFINITION_ID": "715259", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 715259- duloxetine", 
    "CONDITION_CONCEPT_ID": "140673", 
    "CONDITION_CONCEPT_NAME": "Hypothyroidism", 
    "NUM_PERSONS_POST_ITT": "3321", 
    "PT_ITT": "265138.616478", 
    "IR_ITT_1000PP": "12.5255236076694"
  }, 
  {
    "COHORT_DEFINITION_ID": "710062", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 710062- Amitriptyline", 
    "CONDITION_CONCEPT_ID": "75860", 
    "CONDITION_CONCEPT_NAME": "Constipation", 
    "NUM_PERSONS_POST_ITT": "3476", 
    "PT_ITT": "338284.05078", 
    "IR_ITT_1000PP": "10.2753883666262"
  }, 
  {
    "COHORT_DEFINITION_ID": "725131", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 725131- Mirtazapine", 
    "CONDITION_CONCEPT_ID": "31967", 
    "CONDITION_CONCEPT_NAME": "Nausea", 
    "NUM_PERSONS_POST_ITT": "4732", 
    "PT_ITT": "251242.365154", 
    "IR_ITT_1000PP": "18.834403175195"
  }, 
  {
    "COHORT_DEFINITION_ID": "715259", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 715259- duloxetine", 
    "CONDITION_CONCEPT_ID": "441284", 
    "CONDITION_CONCEPT_NAME": "Open-angle glaucoma", 
    "NUM_PERSONS_POST_ITT": "59", 
    "PT_ITT": "285810.667244", 
    "IR_ITT_1000PP": "0.206430363740171"
  }, 
  {
    "COHORT_DEFINITION_ID": "743670", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 743670- venlafaxine", 
    "CONDITION_CONCEPT_ID": "140673", 
    "CONDITION_CONCEPT_NAME": "Hypothyroidism", 
    "NUM_PERSONS_POST_ITT": "2013", 
    "PT_ITT": "192326.923942", 
    "IR_ITT_1000PP": "10.4665532975875"
  }, 
  {
    "COHORT_DEFINITION_ID": "40234834", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 40234834- vilazodone", 
    "CONDITION_CONCEPT_ID": "31967", 
    "CONDITION_CONCEPT_NAME": "Nausea", 
    "NUM_PERSONS_POST_ITT": "324", 
    "PT_ITT": "17555.46639", 
    "IR_ITT_1000PP": "18.4557899404232"
  }, 
  {
    "COHORT_DEFINITION_ID": "710062", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 710062- Amitriptyline", 
    "CONDITION_CONCEPT_ID": "196523", 
    "CONDITION_CONCEPT_NAME": "Diarrhea", 
    "NUM_PERSONS_POST_ITT": "3088", 
    "PT_ITT": "339849.413775", 
    "IR_ITT_1000PP": "9.08637730369732"
  }, 
  {
    "COHORT_DEFINITION_ID": "797617", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 797617- Citalopram", 
    "CONDITION_CONCEPT_ID": "436962", 
    "CONDITION_CONCEPT_NAME": "Insomnia", 
    "NUM_PERSONS_POST_ITT": "2950", 
    "PT_ITT": "652486.410347", 
    "IR_ITT_1000PP": "4.52116695952511"
  }, 
  {
    "COHORT_DEFINITION_ID": "715939", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 715939- Escitalopram", 
    "CONDITION_CONCEPT_ID": "441284", 
    "CONDITION_CONCEPT_NAME": "Open-angle glaucoma", 
    "NUM_PERSONS_POST_ITT": "77", 
    "PT_ITT": "286588.599921", 
    "IR_ITT_1000PP": "0.268677819080122"
  }, 
  {
    "COHORT_DEFINITION_ID": "797617", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 797617- Citalopram", 
    "CONDITION_CONCEPT_ID": "377091", 
    "CONDITION_CONCEPT_NAME": "Seizure", 
    "NUM_PERSONS_POST_ITT": "5329", 
    "PT_ITT": "629854.488134", 
    "IR_ITT_1000PP": "8.46068433327773"
  }, 
  {
    "COHORT_DEFINITION_ID": "797617", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 797617- Citalopram", 
    "CONDITION_CONCEPT_ID": "373995", 
    "CONDITION_CONCEPT_NAME": "Delirium", 
    "NUM_PERSONS_POST_ITT": "3761", 
    "PT_ITT": "648843.065496", 
    "IR_ITT_1000PP": "5.79647098042876"
  }, 
  {
    "COHORT_DEFINITION_ID": "715259", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 715259- duloxetine", 
    "CONDITION_CONCEPT_ID": "373995", 
    "CONDITION_CONCEPT_NAME": "Delirium", 
    "NUM_PERSONS_POST_ITT": "2073", 
    "PT_ITT": "276783.756156", 
    "IR_ITT_1000PP": "7.48960137253005"
  }, 
  {
    "COHORT_DEFINITION_ID": "703547", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 703547- Trazodone", 
    "CONDITION_CONCEPT_ID": "441284", 
    "CONDITION_CONCEPT_NAME": "Open-angle glaucoma", 
    "NUM_PERSONS_POST_ITT": "87", 
    "PT_ITT": "622939.404117", 
    "IR_ITT_1000PP": "0.139660454010483"
  }, 
  {
    "COHORT_DEFINITION_ID": "721724", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 721724- Nortriptyline", 
    "CONDITION_CONCEPT_ID": "436962", 
    "CONDITION_CONCEPT_NAME": "Insomnia", 
    "NUM_PERSONS_POST_ITT": "334", 
    "PT_ITT": "85480.67297", 
    "IR_ITT_1000PP": "3.90731598612027"
  }, 
  {
    "COHORT_DEFINITION_ID": "738156", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 738156- Doxepin", 
    "CONDITION_CONCEPT_ID": "377091", 
    "CONDITION_CONCEPT_NAME": "Seizure", 
    "NUM_PERSONS_POST_ITT": "768", 
    "PT_ITT": "70243.920532", 
    "IR_ITT_1000PP": "10.9333305171959"
  }, 
  {
    "COHORT_DEFINITION_ID": "715259", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 715259- duloxetine", 
    "CONDITION_CONCEPT_ID": "31967", 
    "CONDITION_CONCEPT_NAME": "Nausea", 
    "NUM_PERSONS_POST_ITT": "5674", 
    "PT_ITT": "252687.355919", 
    "IR_ITT_1000PP": "22.4546257147066"
  }, 
  {
    "COHORT_DEFINITION_ID": "725131", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 725131- Mirtazapine", 
    "CONDITION_CONCEPT_ID": "373995", 
    "CONDITION_CONCEPT_NAME": "Delirium", 
    "NUM_PERSONS_POST_ITT": "2416", 
    "PT_ITT": "269572.063786", 
    "IR_ITT_1000PP": "8.96235302007386"
  }, 
  {
    "COHORT_DEFINITION_ID": "743670", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 743670- venlafaxine", 
    "CONDITION_CONCEPT_ID": "75860", 
    "CONDITION_CONCEPT_NAME": "Constipation", 
    "NUM_PERSONS_POST_ITT": "2086", 
    "PT_ITT": "194337.31393", 
    "IR_ITT_1000PP": "10.7339139242779"
  }, 
  {
    "COHORT_DEFINITION_ID": "739138", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 739138- Sertraline", 
    "CONDITION_CONCEPT_ID": "377091", 
    "CONDITION_CONCEPT_NAME": "Seizure", 
    "NUM_PERSONS_POST_ITT": "3487", 
    "PT_ITT": "494701.293344", 
    "IR_ITT_1000PP": "7.04869796565348"
  }, 
  {
    "COHORT_DEFINITION_ID": "722031", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 722031- Paroxetine", 
    "CONDITION_CONCEPT_ID": "31967", 
    "CONDITION_CONCEPT_NAME": "Nausea", 
    "NUM_PERSONS_POST_ITT": "163", 
    "PT_ITT": "13318.620417", 
    "IR_ITT_1000PP": "12.2385048072956"
  }, 
  {
    "COHORT_DEFINITION_ID": "715259", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 715259- duloxetine", 
    "CONDITION_CONCEPT_ID": "377091", 
    "CONDITION_CONCEPT_NAME": "Seizure", 
    "NUM_PERSONS_POST_ITT": "2591", 
    "PT_ITT": "268624.663781", 
    "IR_ITT_1000PP": "9.64542854528186"
  }, 
  {
    "COHORT_DEFINITION_ID": "750982", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 750982- Bupropion", 
    "CONDITION_CONCEPT_ID": "196523", 
    "CONDITION_CONCEPT_NAME": "Diarrhea", 
    "NUM_PERSONS_POST_ITT": "2575", 
    "PT_ITT": "362277.502841", 
    "IR_ITT_1000PP": "7.1078109454954"
  }, 
  {
    "COHORT_DEFINITION_ID": "715939", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 715939- Escitalopram", 
    "CONDITION_CONCEPT_ID": "377575", 
    "CONDITION_CONCEPT_NAME": "Tinnitus", 
    "NUM_PERSONS_POST_ITT": "43", 
    "PT_ITT": "286713.380194", 
    "IR_ITT_1000PP": "0.149975560857693"
  }, 
  {
    "COHORT_DEFINITION_ID": "755695", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 755695- Fluoxetine", 
    "CONDITION_CONCEPT_ID": "373995", 
    "CONDITION_CONCEPT_NAME": "Delirium", 
    "NUM_PERSONS_POST_ITT": "1928", 
    "PT_ITT": "453219.087386", 
    "IR_ITT_1000PP": "4.25401324361688"
  }, 
  {
    "COHORT_DEFINITION_ID": "750982", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 750982- Bupropion", 
    "CONDITION_CONCEPT_ID": "373995", 
    "CONDITION_CONCEPT_NAME": "Delirium", 
    "NUM_PERSONS_POST_ITT": "1834", 
    "PT_ITT": "367771.100537", 
    "IR_ITT_1000PP": "4.9867974871383"
  }, 
  {
    "COHORT_DEFINITION_ID": "743670", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 743670- venlafaxine", 
    "CONDITION_CONCEPT_ID": "436962", 
    "CONDITION_CONCEPT_NAME": "Insomnia", 
    "NUM_PERSONS_POST_ITT": "1072", 
    "PT_ITT": "199952.962193", 
    "IR_ITT_1000PP": "5.36126090977975"
  }, 
  {
    "COHORT_DEFINITION_ID": "738156", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 738156- Doxepin", 
    "CONDITION_CONCEPT_ID": "140673", 
    "CONDITION_CONCEPT_NAME": "Hypothyroidism", 
    "NUM_PERSONS_POST_ITT": "714", 
    "PT_ITT": "70435.047121", 
    "IR_ITT_1000PP": "10.1369989683321"
  }, 
  {
    "COHORT_DEFINITION_ID": "710062", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 710062- Amitriptyline", 
    "CONDITION_CONCEPT_ID": "140673", 
    "CONDITION_CONCEPT_NAME": "Hypothyroidism", 
    "NUM_PERSONS_POST_ITT": "2638", 
    "PT_ITT": "340149.495636", 
    "IR_ITT_1000PP": "7.75541352800643"
  }, 
  {
    "COHORT_DEFINITION_ID": "722031", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 722031- Paroxetine", 
    "CONDITION_CONCEPT_ID": "377091", 
    "CONDITION_CONCEPT_NAME": "Seizure", 
    "NUM_PERSONS_POST_ITT": "109", 
    "PT_ITT": "13495.981084", 
    "IR_ITT_1000PP": "8.07647842135935"
  }, 
  {
    "COHORT_DEFINITION_ID": "721724", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 721724- Nortriptyline", 
    "CONDITION_CONCEPT_ID": "377091", 
    "CONDITION_CONCEPT_NAME": "Seizure", 
    "NUM_PERSONS_POST_ITT": "781", 
    "PT_ITT": "81896.104249", 
    "IR_ITT_1000PP": "9.53647315903353"
  }, 
  {
    "COHORT_DEFINITION_ID": "703547", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 703547- Trazodone", 
    "CONDITION_CONCEPT_ID": "140673", 
    "CONDITION_CONCEPT_NAME": "Hypothyroidism", 
    "NUM_PERSONS_POST_ITT": "5015", 
    "PT_ITT": "591581.206773", 
    "IR_ITT_1000PP": "8.47728079016604"
  }, 
  {
    "COHORT_DEFINITION_ID": "743670", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 743670- venlafaxine", 
    "CONDITION_CONCEPT_ID": "196523", 
    "CONDITION_CONCEPT_NAME": "Diarrhea", 
    "NUM_PERSONS_POST_ITT": "1895", 
    "PT_ITT": "195456.002218", 
    "IR_ITT_1000PP": "9.69527657629275"
  }, 
  {
    "COHORT_DEFINITION_ID": "739138", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 739138- Sertraline", 
    "CONDITION_CONCEPT_ID": "373995", 
    "CONDITION_CONCEPT_NAME": "Delirium", 
    "NUM_PERSONS_POST_ITT": "2067", 
    "PT_ITT": "507527.94096", 
    "IR_ITT_1000PP": "4.07268217802989"
  }, 
  {
    "COHORT_DEFINITION_ID": "703547", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 703547- Trazodone", 
    "CONDITION_CONCEPT_ID": "312327", 
    "CONDITION_CONCEPT_NAME": "Acute myocardial infarction", 
    "NUM_PERSONS_POST_ITT": "2873", 
    "PT_ITT": "610183.393676", 
    "IR_ITT_1000PP": "4.70842050074789"
  }, 
  {
    "COHORT_DEFINITION_ID": "797617", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 797617- Citalopram", 
    "CONDITION_CONCEPT_ID": "31967", 
    "CONDITION_CONCEPT_NAME": "Nausea", 
    "NUM_PERSONS_POST_ITT": "10169", 
    "PT_ITT": "607642.112875", 
    "IR_ITT_1000PP": "16.7351797785811"
  }, 
  {
    "COHORT_DEFINITION_ID": "715259", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 715259- duloxetine", 
    "CONDITION_CONCEPT_ID": "436962", 
    "CONDITION_CONCEPT_NAME": "Insomnia", 
    "NUM_PERSONS_POST_ITT": "1479", 
    "PT_ITT": "278881.538023", 
    "IR_ITT_1000PP": "5.30332703442715"
  }, 
  {
    "COHORT_DEFINITION_ID": "725131", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 725131- Mirtazapine", 
    "CONDITION_CONCEPT_ID": "436962", 
    "CONDITION_CONCEPT_NAME": "Insomnia", 
    "NUM_PERSONS_POST_ITT": "1672", 
    "PT_ITT": "272788.78564", 
    "IR_ITT_1000PP": "6.12928422287323"
  }, 
  {
    "COHORT_DEFINITION_ID": "717607", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 717607- Desvenlafaxine", 
    "CONDITION_CONCEPT_ID": "373995", 
    "CONDITION_CONCEPT_NAME": "Delirium", 
    "NUM_PERSONS_POST_ITT": "314", 
    "PT_ITT": "50429.698639", 
    "IR_ITT_1000PP": "6.22648971685837"
  }, 
  {
    "COHORT_DEFINITION_ID": "703547", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 703547- Trazodone", 
    "CONDITION_CONCEPT_ID": "31967", 
    "CONDITION_CONCEPT_NAME": "Nausea", 
    "NUM_PERSONS_POST_ITT": "9433", 
    "PT_ITT": "568635.777971", 
    "IR_ITT_1000PP": "16.5888260384507"
  }, 
  {
    "COHORT_DEFINITION_ID": "722031", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 722031- Paroxetine", 
    "CONDITION_CONCEPT_ID": "312327", 
    "CONDITION_CONCEPT_NAME": "Acute myocardial infarction", 
    "NUM_PERSONS_POST_ITT": "60", 
    "PT_ITT": "14004.282172", 
    "IR_ITT_1000PP": "4.28440381756684"
  }, 
  {
    "COHORT_DEFINITION_ID": "738156", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 738156- Doxepin", 
    "CONDITION_CONCEPT_ID": "312327", 
    "CONDITION_CONCEPT_NAME": "Acute myocardial infarction", 
    "NUM_PERSONS_POST_ITT": "451", 
    "PT_ITT": "73271.845962", 
    "IR_ITT_1000PP": "6.15516088176482"
  }, 
  {
    "COHORT_DEFINITION_ID": "703547", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 703547- Trazodone", 
    "CONDITION_CONCEPT_ID": "377091", 
    "CONDITION_CONCEPT_NAME": "Seizure", 
    "NUM_PERSONS_POST_ITT": "5179", 
    "PT_ITT": "587806.817364", 
    "IR_ITT_1000PP": "8.81071781920641"
  }, 
  {
    "COHORT_DEFINITION_ID": "743670", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 743670- venlafaxine", 
    "CONDITION_CONCEPT_ID": "31967", 
    "CONDITION_CONCEPT_NAME": "Nausea", 
    "NUM_PERSONS_POST_ITT": "3619", 
    "PT_ITT": "184056.626386", 
    "IR_ITT_1000PP": "19.6624271076788"
  }, 
  {
    "COHORT_DEFINITION_ID": "739138", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 739138- Sertraline", 
    "CONDITION_CONCEPT_ID": "133280", 
    "CONDITION_CONCEPT_NAME": "Alopecia", 
    "NUM_PERSONS_POST_ITT": "28", 
    "PT_ITT": "516832.154845", 
    "IR_ITT_1000PP": "0.0541761957678452"
  }, 
  {
    "COHORT_DEFINITION_ID": "755695", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 755695- Fluoxetine", 
    "CONDITION_CONCEPT_ID": "140673", 
    "CONDITION_CONCEPT_NAME": "Hypothyroidism", 
    "NUM_PERSONS_POST_ITT": "2936", 
    "PT_ITT": "444457.659736", 
    "IR_ITT_1000PP": "6.60580358035439"
  }, 
  {
    "COHORT_DEFINITION_ID": "738156", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 738156- Doxepin", 
    "CONDITION_CONCEPT_ID": "133280", 
    "CONDITION_CONCEPT_NAME": "Alopecia", 
    "NUM_PERSONS_POST_ITT": "8", 
    "PT_ITT": "75258.377974", 
    "IR_ITT_1000PP": "0.106300457375839"
  }, 
  {
    "COHORT_DEFINITION_ID": "703547", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 703547- Trazodone", 
    "CONDITION_CONCEPT_ID": "75860", 
    "CONDITION_CONCEPT_NAME": "Constipation", 
    "NUM_PERSONS_POST_ITT": "6265", 
    "PT_ITT": "591263.099331", 
    "IR_ITT_1000PP": "10.5959597463273"
  }, 
  {
    "COHORT_DEFINITION_ID": "715939", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 715939- Escitalopram", 
    "CONDITION_CONCEPT_ID": "140673", 
    "CONDITION_CONCEPT_NAME": "Hypothyroidism", 
    "NUM_PERSONS_POST_ITT": "2568", 
    "PT_ITT": "271132.901562", 
    "IR_ITT_1000PP": "9.47136988984266"
  }, 
  {
    "COHORT_DEFINITION_ID": "722031", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 722031- Paroxetine", 
    "CONDITION_CONCEPT_ID": "140673", 
    "CONDITION_CONCEPT_NAME": "Hypothyroidism", 
    "NUM_PERSONS_POST_ITT": "123", 
    "PT_ITT": "13479.13783", 
    "IR_ITT_1000PP": "9.12521272141336"
  }, 
  {
    "COHORT_DEFINITION_ID": "710062", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 710062- Amitriptyline", 
    "CONDITION_CONCEPT_ID": "436962", 
    "CONDITION_CONCEPT_NAME": "Insomnia", 
    "NUM_PERSONS_POST_ITT": "1396", 
    "PT_ITT": "349988.267168", 
    "IR_ITT_1000PP": "3.98870513944942"
  }, 
  {
    "COHORT_DEFINITION_ID": "722031", 
    "COHORT_DEFINITION_NAME": "New users (with >365d observation prior to first use) of 722031- Paroxetine", 
    "CONDITION_CONCEPT_ID": "436962", 
    "CONDITION_CONCEPT_NAME": "Insomnia", 
    "NUM_PERSONS_POST_ITT": "64", 
    "PT_ITT": "13941.58813", 
    "IR_ITT_1000PP": "4.59058174744687"
  }
];
